BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31675661)

  • 41. Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation.
    Jeong SH; Moon JH; Kim JS; Yang DH; Park Y; Cho SG; Kwak JY; Eom HS; Won JH; Hong JS; Oh SY; Lee HS; Kim SJ
    Ann Hematol; 2015 Apr; 94(4):617-25. PubMed ID: 25465233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adolescents with acute lymphoblastic leukemia treated at pediatric versus adult hospitals.
    Pole JD; Alibhai SM; Ethier MC; Teuffel O; Portwine C; Zelcer S; Johnston DL; Silva M; Alexander S; Brandwein JM; Sung L
    Ann Oncol; 2013 Mar; 24(3):801-6. PubMed ID: 23108950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial.
    Bader P; Kreyenberg H; von Stackelberg A; Eckert C; Salzmann-Manrique E; Meisel R; Poetschger U; Stachel D; Schrappe M; Alten J; Schrauder A; Schulz A; Lang P; Müller I; Albert MH; Willasch AM; Klingebiel TE; Peters C
    J Clin Oncol; 2015 Apr; 33(11):1275-84. PubMed ID: 25605857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
    Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
    Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
    Guzauskas GF; Villa KF; Vanhove GF; Fisher VL; Veenstra DL
    J Adolesc Young Adult Oncol; 2017 Mar; 6(1):53-61. PubMed ID: 27779442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Stem Cell Transplant on Survival in Adult Patients With Acute Lymphoblastic Leukemia: NCDB Analysis.
    Master S; Koshy N; Mansour R; Shi R
    Anticancer Res; 2019 Apr; 39(4):1899-1906. PubMed ID: 30952731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival after stem-cell transplant in pediatric and young-adult patients with relapsed and refractory B-cell acute lymphoblastic leukemia.
    Crotta A; Zhang J; Keir C
    Curr Med Res Opin; 2018 Mar; 34(3):435-440. PubMed ID: 28945102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multi-center trial based on SCMC-ALL-2005 for children's acute lymphoblastic leukemia].
    SHAQ Multicenter Study Group of Children's Acute Lymphoblastic Leukemia Research
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):495-501. PubMed ID: 24267129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
    Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period.
    Thomas X; Danaïla C; Le QH; Sebban C; Troncy J; Charrin C; Lhéritier V; Michallet M; Magaud JP; Fiere D
    Leukemia; 2001 Dec; 15(12):1811-22. PubMed ID: 11753600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia.
    Muffly L; Yin J; Jacobson S; Wall A; Quiroz E; Advani AS; Luger SM; Tallman MS; Litzow MR; Foster MC; Erba HP; Appelbaum FR; Larson RA; Keegan THM; Stock W
    Blood Adv; 2022 Jul; 6(14):4085-4092. PubMed ID: 35838753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes.
    Dalle JH; Balduzzi A; Bader P; Lankester A; Yaniv I; Wachowiak J; Pieczonka A; Bierings M; Yesilipek A; Sedlaçek P; Ifversen M; Sufliarska S; Toporski J; Glogova E; Poetschger U; Peters C
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1848-1855. PubMed ID: 29772352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic impact of TP53 mutations in adult acute lymphoblastic leukemia treated with a pediatric-type regimen.
    Ou J; Xu X; Deng S; Liang H; Cai Z; Li J; Huang Z; Tang B; Wang Z; Zhou Y; Liu X; Liu Q; Zhou H
    Leuk Lymphoma; 2024 Feb; 65(2):219-227. PubMed ID: 37938093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of insurance and marital status on outcomes of adolescents and young adults with acute lymphoblastic leukemia.
    Fintel AE; Jamy O; Martin MG
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):364-7. PubMed ID: 25592548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment and Prognosis of Adult T Cell Acute Lymphoblastic Leukemia].
    Huang ZF; Wang TY; Fu MW; Liu W; Hao M; Qiu LG; Zou H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):485-491. PubMed ID: 31484610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stem cell transplantation outcomes in lymphoblastic lymphoma.
    Brammer JE; Khouri I; Marin D; Ledesma C; Rondon G; Ciurea SO; Nieto Y; Champlin RE; Hosing C; Kebriaei P
    Leuk Lymphoma; 2017 Feb; 58(2):366-371. PubMed ID: 27348707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical characteristics and outcomes of adults with Philadelphia chromosome positive and/or bcr-abl positive acute lymphoblastic leukemia: a single center study from China.
    Li Y; Zou D; Zhao Y; Mi Y; Wang J; Qiu L
    Leuk Lymphoma; 2010 Mar; 51(3):488-96. PubMed ID: 20141436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults.
    McNeer JL; Bleyer A
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26989. PubMed ID: 29418064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.